bpc 157 cancer cells Everyone’s talking about peptides like this… so let’s actually look at the science., Yes — there is a study on BPC-157 and cancer., But it’s a 2004 conference abstract (not even a full paper), looking BPC 157 Therapy and the

Gastroprotection & Cytoprotection : Consistent with its origin, BPC-157 has repeatedly reduced gastric and intestinal lesion severity in preclinical models and supported mucosal closure.[3] Nitric-Oxide System Balancing : BPC-157 has normalised haemodynamics in settings of both nitric-oxide deficiency and excess, pointing to a homeostatic effect on vascular tone and tissue perfusion

In a Phase II trial in ulcerative colitis, BPC-157 (also referred to by a code like PL 14736) reportedly helped induce remission of the disease and was noted to be well-tolerated with no side effects

Monitoring heavy metal levels is essential for mitigating risks and promoting detoxification

As an unapproved peptide that has not received approval from any governmental health authority for human therapeutic use, it falls within the scope of the S0 catch-all category for non-approved substances and should be treated as prohibited at all times in athletic settings